Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CVS Health Corp (NY: CVS )

58.01 +0.91 (+1.59%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
48 49 Next >
3 Reliable Dividend Stocks You Can Buy With $600
With products and services that many of us can't live without, these businesses are poised to deliver steadily rising dividend payouts. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023 
Via MarketBeat
Over $400M Robinhood Stock Linked To Sam Bankman-Fried, Dell Eyes Reducing Dependence On China, Walgreens Swings To Quarterly Loss: Top Stories Today
Benzinga 
Via Benzinga
2 Medical Stocks to Watch Heading Into 2023
The two healthcare companies easily outdid the S&P 500 this year. 
Via The Motley Fool
If You Invested $100 In This Stock 20 Years Ago, You Would Have $700 Today
Via Benzinga
Here's How Much $1000 Invested In CVS Health 20 Years Ago Would Be Worth Today
Via Benzinga
Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow
Via Benzinga
Why Cano Health's Shares Dropped 27.9% in December
The company, which operates senior-oriented primary care centers, is running low on cash. 
Via The Motley Fool
FDA Permits Retail Pharmacies To Distribute Abortion Pills, Expanding Access After Supreme Court Ruling
Via Benzinga
Are These 2 Dividend Stocks in Danger of Cutting Their Payouts?
These stocks have payout ratios of around 90%, suggesting that their dividend payments may not be sustainable. 
Via The Motley Fool
3 Outstanding Dividend Growth Stocks to Buy for 2023
Steadily growing dividend payments from these stocks could do wonders for your passive income portfolio down the road. 
Via The Motley Fool
3 Beaten Up Healthcare Stocks With Expected Annual Returns Up To 19.2%
3 stocks in the healthcare sector that have a trailing one-year total return of at least -10% or worse, but offer at least 10% total returns over the next five years. 
Via Talk Markets
2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond
Nothing is more reassuring to an income investor than a boost to the dividend. 
Via The Motley Fool
Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug
Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. launch of generic versions of its Exforge, which treats hypertension to lower... 
Via Benzinga
How To Collect Monthly Checks From The Best Companies In The World
The combination of organic dividend raises and dividend reinvestment results in a beautiful cycle. 
Via Talk Markets
Neobank Current Uses Crypto To Build Bridge Between The Haves And The Have Nots
Current is an Andreessen Horowitz-backed disruptor looking to fix the way people bank. “On one hand, there’s currency debasement and its inflationary impacts," the firm's CTO, Trevor Marshall, says.... 
Via Benzinga
3 Dividend Stocks to Buy That Could Gain 26% to 37% in 2023, According to Wall Street
The investment bank analysts who follow these stocks expect impressive gains in addition to their quarterly dividend payments. 
Via The Motley Fool
Looking Into CVS Health's Recent Short Interest
CVS Health's (NYSE:CVS) short percent of float has risen 4.95% since its last report. The company recently reported that it has 13.92 million shares sold short, which is 1.06% of all regular shares... 
Via Benzinga
3 High-Yielding Dividend Stocks You Can Buy and Forget About
These are safe long-term investments to hold that will also provide you with reliable dividend income over the years. 
Via The Motley Fool
This Biotech Company is Pursuing Positive Cash Flow In 2023
Biotech company Agile Therapeutics Inc. (NASDAQ: AGRX) began selling its contraceptive patch in 2021, and the company is pursuing positive cash flow by the end of 2023.  
Via Benzinga
2 Exceptional Dividend Growth Stocks to Buy Now
These companies have histories of rapid payout increases and the means to continue them. 
Via The Motley Fool
Americans Might Face Sporadic Shortages For Children's Flu, Cold Medicine
With the coming of the winter season, federal data shows that flu infections and hospitalizations are rising, in addition to an already busy season for other respiratory viruses, including respiratory... 
Via Benzinga
Our Top 10 Stock Picks for 2023
As investors seek to balance upside and safety heading into 2023, these stock picks for 2023 provide both, and are set to surge. 
Via InvestorPlace
What Does CVS Health's Debt Look Like?
Shares of CVS Health Inc. (NYSE:CVS) decreased by 0.13% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
Barron's Top Weekend Stock Picks: CVS, Chewy, Apple And Confusion On Tesla's China Plant Is Hurting Stock
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read. 
Via Benzinga
3 REITs With The Largest Recent Dividend Hikes
If you’re a serious real estate investment trust (REIT) investor, dividend hikes are like music to your ears. If you already own the stocks that are announcing increases, you’ll receive more money each... 
Via Benzinga
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics Inc (NASDAQ: VERV) at an estimated valuation of over $6.9 million, based... 
Via Benzinga
CVS Health Pilots Remote System To Fill Prescriptions: Report
CVS Health Corp (NYSE: CVS) is piloting a system, enabling pharmacists to process prescriptions in part remotely, in order to tackle the shortage of pharmacists. 
Via Benzinga
Why Cano Health's Shares Dropped 46.9% in November
Lowered guidance and big third-quarter losses worried investors. 
Via The Motley Fool
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.